0 Table of Contents |
1 Home |
2 Regulatory Data |
3 Clinical Data |
4 Known Issues |
5 Visualiser |
6 Testing Tool Box |
7 Artifacts Summary |
7.1 Medicinal Product Logical Model |
7.2 PPL Administrable Product profile |
7.3 PPL Ingredient profile |
7.4 PPL Manufactured Item profile |
7.5 PPL Marketing Authorisation profile |
7.6 PPL Medicinal Product profile |
7.7 PPL Organization |
7.8 PPL Packaged Product profile |
7.9 Processing Profile - Administrable Product |
7.10 Processing Profile - Ingredient |
7.11 Processing Profile - Manufactured Item |
7.12 Processing Profile - Marketing Authorisation |
7.13 Processing Profile - Medicinal Product |
7.14 Processing Profile - Organization |
7.15 Processing Profile - Packaged Product |
7.16 Equivalent Look Up |
7.17 country |
7.18 name-language-correct |
7.19 reference-strength-substance |
7.20 strength-presentation-quantity |
7.21 strength-presentation-ratio |
7.22 strength-presentation-ratio-denominator |
7.23 strength-presentation-ratio-numerator |
7.24 strength-quantity-and-substance |
7.25 strength-ratio-and-substance |
7.26 DRAFT: Medicinal Product in crossborder eP/eD |
7.27 DRAFT: MyHealth@EU medicinal product |
7.28 Medication for clinical workflows |
7.29 SNOMED CT Clinical Drug |
7.30 Medication |
7.31 Medication as manufactured item |
7.32 AD |
7.33 ANY |
7.34 BL |
7.35 CD |
7.36 Class |
7.37 DT |
7.38 EN |
7.39 II |
7.40 INT |
7.41 PQ |
7.42 REAL |
7.43 RTO |
7.44 ST |
7.45 TS |
7.46 Untyped |
7.47 AdministrableDoseForm |
7.48 MedicinalProductClassification |
7.49 MedicinalProductName |
7.50 Country (ISO 3166-1-2) |
7.51 EDQM Administration Device |
7.52 EDQM Administration Method |
7.53 EDQM Basic Dose Form |
7.54 EDQM Closure |
7.55 EDQM Combination Pack |
7.56 EDQM Combined Pharmaceutical Dose Form |
7.57 EDQM Combined Term |
7.58 EDQM Container |
7.59 EDQM Intended Site |
7.60 EDQM Packaging Category |
7.61 EDQM Patient-friendly Term |
7.62 EDQM Pharmaceutical Dose Form |
7.63 EDQM Route of Administration |
7.64 EDQM Unit of Presentation |
7.65 EMA SPOR All Units Combined |
7.66 EMA SPOR ATC |
7.67 EMA SPOR Authorised Dose Form |
7.68 EMA SPOR Country |
7.69 EMA SPOR Domain |
7.70 EMA SPOR Language |
7.71 EMA SPOR Legal Status for the Supply |
7.72 EMA SPOR Marketing Status |
7.73 EMA SPOR Material |
7.74 EMA SPOR Packaging |
7.75 EMA SPOR Pharmaceutical Dose Form |
7.76 EMA SPOR Record Status |
7.77 EMA SPOR Regulatory Entitlement Status |
7.78 EMA SPOR Routes and Methods of Administration |
7.79 EMA SPOR Shelf Life Type |
7.80 EMA SPOR SMS Substances |
7.81 EMA SPOR Unit of Measurement |
7.82 EMA SPOR Unit of Presentation |
7.83 Language (FHIR) |
7.84 MyHealth@EU Unit of Measurement (UCUM) |
7.85 WHO ATC |
7.86 ATC Human EMA |
7.87 Combination Package EMA |
7.88 Combined Pharmaceutical Dose Form EMA |
7.89 Combined Term EMA |
7.90 Country EMA |
7.91 Domain EMA |
7.92 Language EMA |
7.93 Legal Status for the Supply EMA |
7.94 Marketing Status EMA |
7.95 Material EMA |
7.96 Packaging EMA SPOR |
7.97 Pharmaceutical Dose Form EMA |
7.98 Record Status EMA SPOR |
7.99 Regulatory Entitlement Status EMA SPOR |
7.100 Routes and Methods of Administration EMA |
7.101 Substances EMA SPOR SMS |
7.102 Unit of Measurement EMA |
7.103 Unit of Presentation EMA |
7.104 EDQM-SPOR Pharmaceutical dose forms |
7.105 SMS-SNOMED CT substances |
7.106 001-Agen5mg-EE-FullProduct |
7.107 002-Agen10mg-EE-FullProduct |
7.108 003-CefuroximStragen-1-5g-Powder-SE-FullProduct |
7.109 004-Cefuroxime-MIP-1500mg-EE-FullProduct |
7.110 005-CanifugCremolum-EE-FullProduct |
7.111 006-Yaz-002mg3mg-tablet-SE-FullProduct |
7.112 007-Jangee-002mg-3mg-Film-coated-tablet-EE-FullProduct |
7.113 008-Jangee-003mg-3mg-Film-coated-tablet-EE-FullProduct |
7.114 009-Paracetamol-Kabi10mg-1ml-EE-FullProduct |
7.115 010-Clexane-60mg-06ml-EE-FullProduct |
7.116 011-Betaklav500-125-EE-FullProduct |
7.117 012-Panodil-500mg-SolutionInSachet-SE-FullProduct |
7.118 013-LantusSolostar-EE-FullProduct |
7.119 014-CanestenKombi-FI-FullProduct |
7.120 015-CopaliaHCT-EE-FullProduct |
7.121 016-Lodipin-10mg-Capsule-GR-FullProduct |
7.122 Agen-5mg-Tablet-EE-APD |
7.123 Agen-5mg-Tablet-EE-I |
7.124 Agen-5mg-Tablet-EE-MID |
7.125 Agen-5mg-Tablet-EE-MPD |
7.126 Agen-5mg-Tablet-EE-PPD-1109887-A |
7.127 Agen-5mg-Tablet-EE-PPD-1109887-B |
7.128 Agen-5mg-Tablet-EE-RA |
7.129 AMLaccord-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.130 AMLaccord-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.131 AMLaurobindo-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.132 AMLbluefish-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.133 AMLbluefish-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.134 AMLHipres-10mg-Tablet-EE-FullProduct |
7.135 AMLHipres-5mg-Tablet-EE-FullProduct |
7.136 AMLjubilant-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.137 AMLjubilant-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.138 AMLkrka-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.139 AMLkrka-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.140 AMLmedvalley-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.141 AMLmedvalley-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.142 Amlodistad-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.143 Amlodistad-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.144 AMLsandoz-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.145 AMLsandoz-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.146 AMLteva-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.147 AMLteva-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.148 AMLvitabalans-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.149 AMLvitabalans-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.150 AT-Curocef-1500-Powder |
7.151 CanifugCremolum-100mg-Pessary-EE-APD |
7.152 CanifugCremolum-100mg-Pessary-EE-I |
7.153 CanifugCremolum-100mg-Pessary-EE-MID |
7.154 CanifugCremolum-10mg1g-Cream-EE-APD |
7.155 CanifugCremolum-10mg1g-Cream-EE-I |
7.156 CanifugCremolum-10mg1g-Cream-EE-MID |
7.157 CanifugCremolum-EE-Cream-Medication-Item |
7.158 CanifugCremolum-EE-Medication-Clinical |
7.159 CanifugCremolum-EE-MPD |
7.160 CanifugCremolum-EE-Pessary-Medication-Item |
7.161 CanifugCremolum-EE-PPD-1033692 |
7.162 CanifugCremolum-EE-RA |
7.163 Cefuroxime-MIP-1500mg-EE-APD |
7.164 Cefuroxime-MIP-1500mg-EE-I |
7.165 Cefuroxime-MIP-1500mg-EE-MID |
7.166 Cefuroxime-MIP-1500mg-EE-MPD |
7.167 Cefuroxime-MIP-1500mg-EE-PPD-1529940 |
7.168 Cefuroxime-MIP-1500mg-EE-PPD-1529962 |
7.169 Cefuroxime-MIP-1500mg-EE-RA |
7.170 Cefuroxime1500-Medication-Clinical |
7.171 Cefuroxime1500-Powder-Medication-Item |
7.172 CefuroximeMIP-EE-Medication-Clinical |
7.173 CefuroximeMIP-EE-Powder-Medication-Item |
7.174 Clotrimazole-cream-and-pessaries-Medication-Clinical |
7.175 Clotrimazole-Cream-Generic |
7.176 LOC-100000551-KrkaSverige |
7.177 LOC-100002580-Zentiva |
7.178 LOC-100004795-Wolff-Arzneimittel |
7.179 LOC-100009199-Mip |
7.180 Norvasc-10mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |
7.181 Norvasc-5mg-Tablet-SE-IS-MedicinalProductDefinition-BBDL |